Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology

30 Aug 2023

Abstract excerpt

Introduction: Metabolomics technology facilitates studying associations between small molecules and disease processes. Correlating metabolites in cerebrospinal fluid (CSF) with Alzheimer's disease (AD) CSF biomarkers may elucidate additional changes that are associated with early AD pathology and enhance our knowledge of the disease. Methods: The relative abundance of untargeted metabolites was assessed in 161...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37719875
DOI: 10.3389/fnagi.2023.1214932

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologyPMID 37719875Read ↗

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read ↗

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseSemantic proximity Read ↗

Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypesSemantic proximity Read ↗

Cerebrospinal Fluid and Plasma Metabolites with Parkinson’s Disease: A Mendelian Randomization StudySemantic proximity Read ↗

Large-scale proteome and metabolome analysis of CSF implicates altered glucose metabolism and succinylcarnitine in Alzheimer’s diseaseSemantic proximity Read ↗

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read ↗

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s diseaseSemantic proximity Read ↗

Lysophosphatidylcholines are associated with P-tau181 levels in early stages of Alzheimer’s DiseaseSemantic proximity Read ↗

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations.Semantic proximity Read ↗

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity Read ↗

Multiomics profiling of human plasma and CSF reveals ATN derived networks and highlights causal links in Alzheimer’s diseaseSemantic proximity Read ↗

Cerebrospinal fluid and plasma metabolites in Parkinson's disease: a Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.